IP Library Granted Patent US 10,633,676
Granted Patent B2
US 10,633,676 · App. 15/237,190 · Granted Apr 28, 2020

Reverse beta oxidation pathway

Inventors: Ramon Gonzalez (Houston, TX); James Clomburg (Houston, TX); Clementina Dellomonaco (Wilmington, DE); Elliot N. Miller (Houston, TX)
Assignee: William Marsh Rice University
C12P7/16C12N9/001C12N9/0006C12N9/1029C12N9/88C12N15/70C12P5/02C12P5/026C12P7/04C12P7/40C12P7/42C12P7/6409C12Y101/01035C12Y102/0105C12Y103/99003C12Y203/01C12Y402/01017Y02E50/10Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,676
App. No.
15/237,190
Granted
Apr 28, 2020
Kind
B2
Abstract

The invention relates to recombinant microorganisms that have been engineered to produce various chemicals using genes that have been repurposed to create a reverse beta oxidation pathway. Generally speaking, the beta oxidation cycle is expressed and driven in reverse by modifying various regulation points for as many cycles as needed, and then the CoA thioester intermediates are converted to useful products by the action of termination enzymes.

Claims (27)

1. A method of making a product, comprising growing an engineered microorganism in a nutrient broth for a time sufficient to make a product, and isolating said product, wherein said product is selected from the group consisting of carboxylic acids, alkanes, or alkenes, wherein said engineered microorganism comprises:

a) overexpression of β-oxidation cycle enzymes as compared to a corresponding wild type microorganism, wherein said enzymes comprise:

i) a thiolase catalyzing the conversion of (C n )-acyl CoA to β-ketoacyl-CoA;

ii) a hydroxyacyl-coA dehydrogenase catalyzing the conversion of β-ketoacyl-CoA to β-hydroxyacyl-CoA;

iii) an enoyl-coA hydratase catalyzing the conversion of β-hydroxyacyl-CoA to trans-Δ2-enoyl-coA; and

iv) an acyl-CoA dehydrogenase or a transenoyl-CoA reductase catalyzing the conversion of trans-Δ2-enoyl-coA to (C n+2 )-acyl CoA;

b) functional operation of a β-oxidation cycle in a reverse biosynthetic direction as recited in steps i) to iv); and

c) overexpression of one or more termination enzyme(s) as compared to a corresponding wild type microorganism, wherein said termination enzyme(s) are selected from:

i) an alcohol-forming coenzyme-A thioester reductase, or an aldehyde-forming CoA thioester reductase plus an alcohol dehydrogenase, to convert intermediates produced by reversal of the β-oxidation cycle to trans Δ2 fatty alcohols, β-keto alcohols, 1,3 diols, or β-hydroxy acids;

ii) a thioesterase, or an acyl-CoA:acetyl-CoA transferase, or a phosphotransacylase and a carboxylate kinase, to convert intermediates produced by reversal of the β-oxidation cycle to carboxylic acids;

iii) an aldehyde-forming CoA thioester reductase and an aldehyde decarbonylase, to convert intermediates produced by reversal of the β-oxidation cycle to alkanes or terminal alkenes; and

iv) one or more olefin-forming enzymes to convert intermediates produced by reversal of the β-oxidation cycle to alkenes.

2. The method of claim 1 , further comprising supplementing said nutrient broth with propionate in order to produce odd-chain length products.

3. The method of claim 1 , further comprising growing said engineered microorganism under microaerobic (<10% O 2 ) or anaerobic conditions at a temperature of 30-40° C., wherein said nutrient broth comprises 0-100 μM FeSO 4 and 0-5 mM calcium pantothenate.

4. The method of claim 1 , wherein said one or more olefin-forming enzymes are selected from:

OleA, OleB, OleC, and OleD.

5. The method of claim 4 , wherein said engineered microorganism comprises a genotype selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, ΔydiO, [yqeF+, tesB+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, fadM+]; and

c) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, yciA+].

6. The method of claim 4 , wherein said engineered microorganism comprises a genotype selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, acrM+, PCC7942_orf1593+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, acrM+, PCC7942_orf1593+];

c) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, oleABCD+,];

d) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, acrM+, PCC7942_orf1593+];

e) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, acr1+, PCC7942_orf1593+]; and

f) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, oleABCD+,].

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2017
From: GONZALEZ, RAMON; CLOMBURG, JAMES M; DELLOMONACO, CLEMENTINA; MILLER, ELLIOT N
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 042392/0338 →
Continuity (3)
Continuation 13983885
Provisional Application 61440192 · Feb 7, 2011
Related Publication 20170088862A1 · Mar 30, 2017